Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-462-0 | CAS number: 95-88-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 25.08.2004 - 24.09.2004
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- GLP compliance:
- yes
Test material
- Reference substance name:
- 4-chlororesorcinol
- EC Number:
- 202-462-0
- EC Name:
- 4-chlororesorcinol
- Cas Number:
- 95-88-5
- Molecular formula:
- C6H5ClO2
- IUPAC Name:
- 4-chlorobenzene-1,3-diol
- Test material form:
- other:
- Remarks:
- beige powder
- Details on test material:
- Molecular weight: 144.65
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Details on test animals or test system and environmental conditions:
- Age at pairing: 11 weeks minimum
Body weights (day 0 post coitum): 190 - 236 grams
Acclimatization: five days prior to pairing under test conditions with an evaluation of the health status
Conditions: animals were housed under standard laboratory conditions: air-conditioned with 10-15 air changes per hour; the environment monitored continuously with recordings of temperature (target range 22 +/- 5°C) and relative humidity (target range 30 - 70%), 12 hours artificial fluorescent light / 12 hours dark with background music played at a centrally defined low volume for at least 8 hours during the light period
Accomodation: animals were housed individually in Makrolon cages (type-3) with wire mesh tops and standardized granulated softwood bedding (Lignocel, Schill AG, CH-4132 MuttenzlSwitzerland)
Diet: pelleted standard Kliba-Nafag 3433 rat/mouse maintenance diet (Provimi Kliba AG, CH-4303 Kaiseraugstl Switzerland) was available ad libitum
Water: community tap water from Füllinsdorf in bottles was available ad libitum
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: ultrapure water
- Details on exposure:
- A standard dose volume of 10 ml/kg body weight with a daily adjustment to the actual body weight was used.
- Details on mating procedure:
- After acclimatization, females were housed with sexually mature males (1:1) in special automatic mating cages, i.e. with synchronized timing to initiate the nig htly mating period, until evidence of copulation was observed. This system reduced the variation in the copulation times of the different females.
The females were removed and housed individually, if:
a) the daily vaginal smear was sperm positive. or
b) a copulation plug was observed.
The day of mating was designated day 0 post coitum. Male rats of the Same source and strain were used for mating only. These male rats were in the possession of RCC, and were not considered part of the test system. The fertility of these males had been proven and was continuously monitored. - Duration of treatment / exposure:
- from day 6 through to day 20 post coitum
- Frequency of treatment:
- once daily
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day
- Remarks:
- group 1 (vehicle control)
- Dose / conc.:
- 50 mg/kg bw/day
- Remarks:
- group 2
- Dose / conc.:
- 100 mg/kg bw/day
- Remarks:
- group 3
- Dose / conc.:
- 200 mg/kg bw/day
- Remarks:
- group 4
- No. of animals per sex per dose:
- 22 mated female rats
- Control animals:
- yes
Examinations
- Maternal examinations:
- General Tolerability
All females survived until scheduled Caesarean section.
In group 4, following administration of the test item clonic spasms or tremor were noted for all females on all treatment days. In group 3, following administration of the test item tremor was noted for all females during the first six to eleven treatment days. These clinical signs were considered to be test item related. No test item-related macroscopic findings were noted at necropsy.
Food Consumption and Body Weights
No test item-related effects on mean food consumption or body weight gain were noted at any dosage applied.
Also corrected body weight gain (corrected for gravid uterus weights) did not give an indication of test item-related effects.
Reproduction Data
The pregnancy rate was 100% and the mean numbers of Corpora lutea and implantation sites were similar in all groups. Post-implantation losses and the mean number of fetuses per dam were unaffected by treatment with the test item at all dose levels. - Fetal examinations:
- Body Weights and Sex Ratios
Mean fetal body weights were similar in all groups and gave no indication of a test itemrelated effect.
No test item-related effects on fetal Sex ratios were noted in any group.
External Examination
No abnormalities were noted during external examination of fetuses.
Visceral and Skeletal Examination
No test item-related findings were noted during fetal visceral, skeletal or cartilage examination.
Results and discussion
Results: maternal animals
Effect levels (maternal animals)
- Key result
- Dose descriptor:
- NOEL
- Effect level:
- 50 mg/kg bw/day
- Based on:
- test mat.
- Basis for effect level:
- body weight and weight gain
- clinical signs
- food consumption and compound intake
- number of abortions
- pre and post implantation loss
Results (fetuses)
Effect levels (fetuses)
- Key result
- Dose descriptor:
- NOEL
- Effect level:
- 200 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- changes in sex ratio
- fetal/pup body weight changes
- external malformations
- skeletal malformations
- visceral malformations
Overall developmental toxicity
- Developmental effects observed:
- no
Applicant's summary and conclusion
- Conclusions:
- In order to detect effects on embryonic and fetal development in pregnant rats, A 012 was administered orally by gavage once daily from day 6 through to day 20 post coitum at dose levels of 0, 50, 100 and 200 mg/kg body weight/day.
Treatment with the test item at 200 and 100 mg/kg body weightlday resulted in dose dependent clinical signs following administration of the test item (clonic spasms and tremor).
Based on these results the NOEL (no observed effect level) for maternal organisms was considered to be 50 mg/kg body weight/day.
Based on these results the NOEL (no observed effect level) for embryo-fetal organisms was considered to be 200 mg/kg body weight/day.
Under the conditions described for this study A 012 did not reveal any teratogenic potential up to and including the highest dose level of 200 mg/kg body weight/day. - Executive summary:
The purpose of this study was to assess the effects of A 012 on embryonic and fetal development when administered orally by gavage once daily to mated female rats from day 6 through to day 20 post coitum, inclusive.
Each group consisted of 22 mated female rats and A 012 was administered at dose levels of :
Group 1 : 0 mglkg body weight/day (vehicle control)
Group 2: 50 mglkg body weight/day
Group 3: 1 00 mglkg body weight/day
Group 4: 200 mglkg body weight/day
A standard dose volume of 10 ml/kg body weight with a daily adjustment to the actual body weight was used. Control animals were dosed with the vehicle alone (ultrapure water).
All females were sacrificed on day 21 post coitum and the fetuses were removed by Caesarean section. Examination of dams and fetuses was performed in accordance with international recommendations.
The following results were obtained:
MATERNAL DATA
General Tolerability
All females survived until scheduled Caesarean section.
In group 4, following administration of the test item clonic spasms or tremor were noted for all females on all treatment days. In group 3, following administration of the test item tremor was noted for all females during the first six to eleven treatment days. These clinical signs were considered to be test item related.
No test item-related macroscopic findings were noted at necropsy.
Food Consumption and Body Weights
No test item-related effects on mean food consumption or body weight gain were noted at any dosage applied.
Also corrected body weight gain (corrected for gravid uterus weights) did not give an indication of test item-related effects.
Reproduction Data
The pregnancy rate was 100% and the mean numbers of Corpora lutea and implantation sites were similar in all groups. Post-implantation losses and the mean number of fetuses per dam were unaffected by treatment with the test item at all dose levels.
FETAL DATA
Body Weights and Sex Ratios
Mean fetal body weights were similar in all groups and gave no indication of a test itemrelated effect.
No test item-related effects on fetal Sex ratios were noted in any group.
External Examination
No abnormalities were noted during external examination of fetuses.
Visceral and Skeletal Examination
No test item-related were noted during fetal visceral, skeletal or cartilage examination.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.